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Neural cell adhesion molecule (NCAM) has been described as a family of membrane glycoproteins. How- 
ever, soluble NCAM immunoreactivity has long been recognized. We here show that soluble NCAM is com- 
posed of two quantitatively major polypeptides of M, 180 000 and I 15 000 and two minor components of 
M, 160 000 and 145 000. Soluble NCAM was immunochemically identical to membrane NCAM, was poly- 
sialylated and carried the HNK-I epitope. It only constituted 0.8% of total NCAM in newborn rat brain. 
Soluble NCAM appeared in neuronal cell culture medium 15-30 min after the start of synthesis preceding 
accumulation of membrane-associated NCAM on the cell surface. This indicates that soluble NCAM con- 
tains a secreted component. 
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1. INTRODUCTION 
Nearly all biochemical analyses on the neural 
cell adhesion molecule NCAM have been per- 
formed on membrane-bound forms of the 
molecule. However, soluble forms of NCAM have 
been observed in body fluids [l] and cell culture 
media [2]. 
The membrane-associated forms of NCAM con- 
sist of three polypeptides: A (Mr -190000), B (Mr 
-135000) and C (Mr -115000). The NCAM-A 
and -B polypeptides are integral membrane pro- 
teins, whereas -C lacks a transmembrane domain 
and is held in the membrane by a covalently bound 
phosphatidylinositol anchor. NCAM-C can be 
partly recovered in a membrane-free supernatant 
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[3-51. Membrane-associated NCAM polypeptides 
are subjected to several posttranslational modifica- 
tions including polysialylation, which in 
vertebrates has so far been demonstrated only on 
NCAM [6]. Approx. 1520% of membrane-bound 
NCAM carries a terminal 3-sulphoglucuronyl 
residue which is involved in adhesion and is 
recognized by the monoclonal antibodies HNK-1 
and L2 [7]. 
The purpose of this study was to characterize the 
soluble NCAM forms in brain and determine their 
relationship with the membrane-associated NCAM 
polypeptides. 
2. MATERIALS AND METHODS 
Rabbit antibodies to rat NCAM were made as 
described by Rasmussen et al. [8]. Horse antiserum 
against E. coli polysialic acid (PSA) residues was a 
gift from Drs F.A. Troy (University of California) 
and J. Robbins (NIH). Monoclonal mouse an- 
tibody against the HNK-1 epitope was obtained 
from the culture supernatant of HNK-1 hybridoma 
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cells purchased from the American Type Culture 
Collection (Rockville, MD). 
Monolayer cultures of fetal rat cerebral neurons 
were prepared as in [9]. The cultures were main- 
tained for 4-6 days before labelling experiments 
and immunoprecipitation in gels was performed as 
described [9]. 
For radioiodination [lo] we used the superna- 
tant of newborn rat brain homogenized in 100 mM 
potassium phosphate buffer (pH 7.1), 100 U/ml 
aprotinin, centrifuged at 100000 x g for 3 h. For 
quantitation by enzyme immunoassay (ELISA 
[l 11) and preparation of material for immunosor- 
bent chromatography homogenates were cen- 
trifuged at 45000 x g for 3 h. Soluble NCAM was 
isolated by an munosorbent technique using 
polyclonal rabbit antibodies to NCAM coupled to 
agarose. 
To demonstrate PSA residues, immunoisolated 
soluble NCAM was incubated with anti-PSA an- 
tiserum or horse preimmune serum. After 30 min 
the fraction of unprecipitated NCAM was deter- 
mined by rocket immunoelectrophoresis [121. 
Similarly, for demonstration of the HNK-1 
epitope, the NCAM preparation was incubated 
with the monoclonal antibody HNK-1 of the IgM 
class or with IgM antibody from an unrelated 
hybridoma clone. After incubation, antigen- 
antibody complexes were precipitated with a rabbit 
antibody to mouse immunoglobulins, and the frac- 
tion of unprecipitated NCAM was measured as 
above. 
3. RESULTS AND DISCUSSION 
The amount of soluble NCAM in newborn rat 
brain was determined by ELISA. The total NCAM 
concentration in solubilized brain homogenates 
was 950 + 30 pg per g brain wet wt (means + SE; 
n = 4). The soluble NCAM concentration was only 
7.1 & 0.1 pug per g brain (n = 4), corresponding to 
0.8% of total NCAM. Assuming that the volume 
of the extracellular space is 15-20% of the tissue 
[ 131, it can be calculated that the concentration of 
soluble NCAM here is 3%5Opg/ml which is con- 
siderably higher than that in CSF (0.6 pg/ml [l]). 
The immunochemical relationship between solu- 
ble and membrane-bound forms of NCAM was in- 
vestigated by comparing conditioned media from 
34 
neuronal cultures and supernatant from newborn 
rat brain with detergent extracts of membranes 
from newborn rat brain. The preparations were 
compared immunochemically using a polyclonal 
rabbit antibody raised against membrane NCAM 
by an immunotitration experiment using ELISA. 
Dilution curves of all three samples were found to 
be parallel, indicating immunochemical identity 
(not shown). 
Membrane NCAM from newborn brain is 
polysialylated and a fraction of NCAM-A and -B 
carries the HNK-1 epitope [7]. We found that anti- 
PSA antiserum was able to precipitate -65% of 
soluble NCAM from newborn rat brain (fig.1). 
HNK-1 antibody was able to precipitate -30% of 
soluble NCAM (not shown). Thus, both modifica- 
tions are present on a fraction of soluble NCAM, 
further substantiating the relationship with the 
membrane forms of the molecule. 
The composition of soluble NCAM in brain was 
studied by radioiodination of supernatants ob- 
tained from homogenates of newborn rat brains. 
After labelling, NCAM was isolated by immuno- 
precipitation and submitted to SDS-PAGE (see 
fig.2, lane 1). For comparison the polypeptide 
composition of membrane-bound NCAM at the 
same age is shown in lane 2. It can be seen that 
NCAM in brain supernatant is composed of a ma- 
jor polypeptide of 180 kDa as well as two minor 
components of 160 and 145 kDa which all migrate 
distinctly differently from the membrane-bound 
forms. Occasionally, a 115 kDa polypeptide 
migrating as NCAM-C occurred. 
A similar pattern was observed in radioiodinated 
media from cultured fetal rat cerebral neurons (not 
shown) or in chase media from biosynthetically 
labelled cells (fig.2, lane 3). No difference in 
polypeptide pattern was observed between media 
centrifuged for 3 h at 100000 x g or 30 min at 
12000 x g. To determine whether soluble NCAM 
was secreted into the extracellular space or derived 
from the membrane-associated forms, we deter- 
mined the rate of appearance of soluble NCAM in 
media from cultured fetal rat brain neurons (fig.3). 
In three out of four experiments the highest rate of 
secretion was found 15-30 min after synthesis had 
begun and only in one experiment was the highest 
rate of secretion found later (30-45 min after the 
start of synthesis). Since membrane-associated 
NCAM has been shown to appear at the cell sur- 
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Fig.1. Demonstration of PSA residues in soluble 
NCAM. Rocket immunoelectrophoresis against 
polyclonal anti-NCAM of an NCAM standard 
(32 pg/ml) in dilutions 1: 1, 1: 2, 1: 4 and 1: 8 (wells l-4) 
and soluble NCAM with anti-PSA (well 5) or 
preimmune horse serum (well 6). 
face approx. 35 min after synthesis [6] these ex- 
periments indicate that at least some of the soluble 
NCAM polypeptides are secreted rather than 
derived from the membrane-associated forms. In 
contrast, similar experiments with another neural 
cell adhesion molecule, Ll [ 141, showed a low and 
constant release of Ll dpm (-150) during the 
whole experimental period. Soluble Ll is assumed 
to be derived from membrane Ll by degradation 
1151. 
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Fig.2. Polypeptide composition of soluble NCAM. 
NCAM was immunoisolated from radioiodinated 
supernatants (lane 1) or membranes (lane 2) from 
newborn rat brain and analysed by SDS-PAGE. (Lane 3) 
NCAM from chase medium, of fetal rat neuronal 
cultures labelled for 5 h with [35S]methionine followed 
by 19 h chase in the presence of 100 U/ml aprotinin. 
Molecular masses (in kDa) and the positions of NCAM- 
A and -B are indicated. Lane 3 was run on a separate gel. 
Experiment no. 
Fig.3. Secretion of NCAM. In four separate xperiments 
a neuronal cell culture was labelled for 15 min with 
[3’S]methionine followed by three successive chase 
periods of 15 min. NCAM was immunoisolated from 
each of the three chase media and secretion determined 
setting the total amount of NCAM dpm (-500) isolated 
from the three chase media to 100%. (Hatched bars) 
Fraction secreted in the period 15-30 min after the start 
of synthesis; (unfilled bars) 30-45 min after start of 
synthesis; (dotted bars) 45-60 min. 
The exact relationship between soluble and 
membrane-bound NCAM remains to be fully 
elucidated. We find it unlikely that the soluble 
180 kDa NCAM is derived from NCAM-A as this 
polypeptide is a 190 kDa integral membrane pro- 
tein with a cytoplasmic domain of -30 kDa [16]. 
Furthermore, the secretion data suggest that at 
least some soluble NCAM is present in the media 
before NCAM appears on the cell surface. We 
therefore suggest hat the 180 kDa form is a new 
member of the NCAM polypeptide family. Five 
species of NCAM mRNA have been detected in 
mouse brain [17]. Three of these give rise to the 
membrane-associated polypeptides A, B and C, 
whereas translation products of the remaining two 
are unknown so far. One of these may code for the 
180 kDa polypeptide. The soluble 115 kDa 
polypeptide, on the other hand, may be derived 
from NCAM-C. The presence of the HNK-1 
epitope on soluble NCAM, however, cannot be at- 
tributed to NCAM-C shed from the membrane, as 
the C polypeptide does not carry this epitope [7]. 
Further studies on the origin of the different 
soluble NCAM polypeptides are currently being 
performed in our laboratory. 
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